Ellevest Inc’s Spruce Biosciences SPRB Stock Holding History

Ellevest Inc’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2	Closed	-$1K	–	1666
2021 Q4	$1K	Buy	+2	New	+$595	﹤0.01%	1349
2021 Q3	–	Hold	0	–	–	–	1611

Other funds holding SPRB

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ellevest Inc's SPRB Position: Q1 2022 in Review

Ellevest Inc sold out of Spruce Biosciences (SPRB) in Q1 2022, closing a stake of 2 shares — an estimated $1K sold.

Ellevest Inc first reported a position in SPRB in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 43 funds tracked by Wall St. Rank hold SPRB as of Q1 2022.

Ellevest Inc reported no remaining Spruce Biosciences position as of Q1 2022 after selling out during the quarter.
Ellevest Inc sold 2 Spruce Biosciences shares in Q1 2022, an estimated $1K.
Ellevest Inc first reported a position in Spruce Biosciences in Q4 2021 and held it in 1 quarter.
Ellevest Inc's Spruce Biosciences position peaked at $1K in Q4 2021.
43 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2022.

Based on Ellevest Inc's 13F filing for Q1 2022, filed 19 Apr 2022.